JS4-2Molecular Targeting Agents and Cardiovascular Adverse Events

Annals of Oncology - United Kingdom
doi 10.1093/annonc/mdy359.001
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV